¸ð¹ÙÀÏ ECG ¸ð´ÏÅ͸µ ½ÃÀåÀº CAGR 5.06%·Î 2025³â 20¾ï 9,000¸¸ ´Þ·¯¿¡¼ 2030³â¿¡´Â 26¾ï 7,500¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°è ¸ð¹ÙÀÏ ½ÉÀüµµ ¸ð´ÏÅ͸µ ½ÃÀåÀº ½ÉÇ÷°ü Áúȯ(CVDs) À¯º´·ü Áõ°¡, ¿þ¾î·¯ºí ¼¾¼ ±â¼úÀÇ ¹ßÀü, ÇコÄɾ¼ Á¤º¸±â¼ú(IT)ÀÇ ¿ªÇÒ È®´ë µîÀ» ¹è°æÀ¸·Î 2025³âºÎÅÍ 2030³â±îÁö Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿þ¾î·¯ºí ±â±â, ½º¸¶Æ®Æù, ÅÂºí¸´, ÈÞ´ë¿ë ¼ö½Å±â¸¦ Æ÷ÇÔÇÑ ¸ð¹ÙÀÏ ECG ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº ½Ç½Ã°£ ½ÉÀå ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ȯÀÚÀÇ °á°ú¿Í ÀÓ»óÀÇÀÇ È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é Àü ¼¼°è »ç¸Á¿øÀÎ 1À§´Â CVD·Î, Á¢±Ù¼ºÀÌ ÁÁÀº ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖÁö¸¸, ¾Æ½Ã¾ÆÅÂÆò¾çÀº °Ç°¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡¿Í °í·ÉÈ·Î ÀÎÇØ ºü¸¥ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í ³ôÀº µð¹ÙÀ̽º ºñ¿ë µîÀÌ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡
CVDÀÇ ¼¼°è ºÎ´ãÀº ¸ð¹ÙÀÏ ½ÉÀüµµ ¸ð´ÏÅ͸µ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¸Å³â ¼ö¹é¸¸ ¸íÀÇ È¯ÀÚ°¡ ¹ß»ýÇϰí ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ ºñħ½ÀÀû ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Çʿ伺Àº ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¸ð¹ÙÀÏ ECG ÀåÄ¡´Â ºÎÁ¤¸Æ ¹× ±âŸ ½ÉÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÏ¿© Ä¡¸íÀûÀÎ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö ÀÖ´Â À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. °íÇ÷¾Ð, ´ç´¢º´, ºñ¸¸ µîÀÇ À§Çè¿äÀÎÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ƯÈ÷ ¿ø°Ý ȯÀÚ °ü¸® ¹× ¿ø°Ý ÀÇ·á ÅëÇÕÀ» Áö¿øÇÏ´Â ¿þ¾î·¯ºí ¸ð´ÏÅÍ¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
¿þ¾î·¯ºí ¼¾¼ ±â¼úÀÇ ¹ßÀü
¼¾¼ÀÇ Á¤È®µµ Çâ»ó°ú ¼ÒÇüÈ µî ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅÍÀÇ ±â¼ú Çõ½ÅÀº ȯÀÚ¿Í ÀÓ»óÀÇÀÇ °æÇèÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ½º¸¶Æ®¿öÄ¡³ª ÈäºÎ ÆÐÄ¡¿Í °°Àº ÀåÄ¡´Â ÇöÀç ÀÇ·á¿ë ECG ±â´É, ½º¸¶Æ®Æù°úÀÇ ¿øÈ°ÇÑ µ¥ÀÌÅÍ ÅëÇÕ, ½Ç½Ã°£ ºÐ¼® ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ƯÈ÷ °íÀ§Ç豺¿¡ ´ëÇÑ »çÀü ¿¹¹æÀû ¸ð´ÏÅ͸µÀÌ °¡´ÉÇØÁ® °¡Á¤ ¹× ÀÓ»ó ÇöÀå¿¡¼ÀÇ µµÀÔÀ» ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
ÇコÄÉ¾î ºÐ¾ßÀÇ IT ÅëÇÕ È®´ë
ECG µ¥ÀÌÅÍ ºÐ¼®À» À§ÇÑ Å¬¶ó¿ìµå ±â¹Ý Ç÷§Æû, ÀΰøÁö´É(AI) µî ÇコÄɾ¼ ITÀÇ ¿ªÇÒÀÌ È®´ëµÇ¸é¼ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ECG ½Ã½ºÅÛÀº IT ÀÎÇÁ¶ó¸¦ Ȱ¿ëÇÏ¿© ½Ç½Ã°£ µ¥ÀÌÅÍ Àü¼Û, ¿ø°Ý Áø´Ü, ÀüÀÚ ÀÇ·á ±â·Ï(EHR)°úÀÇ ÅëÇÕÀ» ½ÇÇöÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿¬°á¼ºÀº ƯÈ÷ µðÁöÅÐ ÀÎÇÁ¶ó°¡ ¹ß´ÞÇÑ Áö¿ª¿¡¼ Áø·á Á¶Á¤À» °ÈÇÏ°í ¿ø°Ý ÀÇ·á ÀÌ´Ï¼ÅÆ¼ºê¸¦ Áö¿øÇϱ⠶§¹®¿¡ ¸ð¹ÙÀÏ ECG ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
¸ð¹ÙÀÏ ½ÉÀüµµ ¸ð´ÏÅ͸µ ½ÃÀåÀº ¹Î°¨ÇÑ ÀÇ·á Á¤º¸°¡ ³×Æ®¿öÅ©¸¦ ÅëÇØ Àü¼ÛµÇ±â ¶§¹®¿¡ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È ¹®Á¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ HIPAA¿Í °°Àº ±ÔÁ¦ Áؼö´Â Á¦Á¶¾÷ü¿¡°Ô º¹À⼺°ú ºñ¿ëÀ» °¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ÀÇ·á ¿¹»êÀÌ ÇÑÁ¤µÈ °³¹ßµµ»ó±¹¿¡¼´Â °í°¡ÀÇ Àåºñ ºñ¿ëÀÌ Á¢±Ù¼ºÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹èÅ͸® ¼ö¸í, ½ÅÈ£ÀÇ Á¤È®¼º µî ±â¼úÀûÀÎ ¹®Á¦µµ º¸±Þ¿¡ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¾ÈÀüÇÏ°í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» ÅëÇØ ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ´Â °ÍÀÌ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ÇʼöÀûÀÔ´Ï´Ù.
The mobile ECG monitoring market is expected to grow from USD 2.090 billion in 2025 to USD 2.675 billion in 2030, at a CAGR of 5.06%.
The global mobile ECG monitoring market is projected to achieve sustainable growth from 2025 to 2030, driven by the rising prevalence of cardiovascular diseases (CVDs), advancements in wearable sensor technology, and the expanding role of information technology (IT) in healthcare. Mobile ECG monitoring systems, encompassing wearable devices, smartphones, tablets, and portable receivers, enable real-time cardiac monitoring, improving patient outcomes and clinician efficiency. As the leading cause of death globally, according to the World Health Organization, CVDs underscore the urgent need for accessible monitoring solutions. North America holds the largest market share, while Asia-Pacific is expected to exhibit rapid growth due to increasing health awareness and an aging population. Challenges include data privacy concerns and high device costs. onward.
Market Drivers
Rising Prevalence of Cardiovascular Diseases
The global burden of CVDs is a primary driver of the mobile ECG monitoring market. With millions affected annually, the need for continuous, non-invasive monitoring solutions is critical. Mobile ECG devices enable early detection of arrhythmias and other cardiac issues, reducing the risk of fatal outcomes. The growing incidence of risk factors like hypertension, diabetes, and obesity further amplifies demand, particularly for wearable monitors that support remote patient management and telehealth integration.
Advancements in Wearable Sensor Technology
Technological innovations in wearable cardiac monitors, such as improved sensor accuracy and miniaturization, are enhancing patient and clinician experiences. Devices like smartwatches and chest patches now offer medical-grade ECG capabilities, seamless data integration with smartphones, and real-time analytics. These advancements enable proactive monitoring, particularly for high-risk patients, driving adoption in home and clinical settings and supporting market growth.
Growing IT Integration in Healthcare
The expanding role of IT in healthcare, including cloud-based platforms and artificial intelligence (AI) for ECG data analysis, is fueling market expansion. Mobile ECG systems leverage IT infrastructure to provide real-time data transmission, remote diagnostics, and integration with electronic health records (EHRs). This connectivity enhances care coordination and supports telehealth initiatives, particularly in regions with advanced digital infrastructure, boosting demand for mobile ECG solutions.
Market Restraints
The mobile ECG monitoring market faces challenges due to data privacy and security concerns, as sensitive health information is transmitted over networks. Regulatory compliance with standards like HIPAA in the U.S. adds complexity and costs for manufacturers. Additionally, high device costs may limit accessibility, particularly in developing regions with limited healthcare budgets. Technical issues, such as battery life and signal accuracy, also pose barriers to widespread adoption. Addressing these challenges through secure, cost-effective solutions will be critical for sustained market growth.
Market Segmentation
By Device Type
The market is segmented into wearables, tablets and smartphones, portable ECG receivers, and others. Wearables, including smartwatches and patches, dominate due to their portability and user-friendly interfaces, appealing to both home users and clinicians. Tablets and smartphones are growing segments, leveraging widespread device ownership for ECG apps, while portable receivers are used in clinical settings for precise diagnostics.
By End-User
The market includes home and personal use, hospitals and clinics, and ambulatory surgical centers. Home and personal use is the fastest-growing segment, driven by increasing health awareness and telehealth adoption. Hospitals and clinics hold a significant share due to their reliance on mobile ECG devices for patient monitoring and diagnostics.
By Geography
The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads, driven by early adoption of innovative technologies, high CVD prevalence, and robust healthcare infrastructure. Asia-Pacific is expected to grow rapidly, fueled by rising health awareness, an aging population (notably in Japan), and increasing healthcare investments in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets, supported by improving healthcare systems.
The mobile ECG monitoring market is set for robust growth from 2025 to 2030, driven by the rising prevalence of CVDs, advancements in wearable sensor technology, and IT integration in healthcare. Despite challenges like data privacy and high costs, the market's outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on secure, affordable, and user-friendly devices to capitalize on the growing demand for mobile ECG solutions in addressing global cardiovascular health challenges.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Different segments covered under the mobile ECG monitoring market report are as below: